Home Positive Topline Results from Phase 3 study of Doria® in Patients with Schizophrenia

Positive Topline Results from Phase 3 study of Doria® in Patients with Schizophrenia

Find out more …

General Information
of the Company
Financial and
Economic Information
Corporate Governance
Information for Investors
Contact
Read time: 0 mins
Positive Topline Results from Phase 3 study of Doria® in Patients with Schizophrenia
https://rovi.es/sites/default/files/PR_Doria%20Phase%20III%20results_0.pdf
Year: 
2019